Diphenylether

Diphenylether

SCHEMBL1830446

CC(=O)O.c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Diphenylether. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 4/20 0.67
TSHR P16473 1/20 0.67
PARP10 Q53GL7 1/20 0.58
NR1H2 P55055 1/20 0.56
BAX Q07812 1/20 0.56
SRD5A2 P31213 2/20 0.56
AKR1C3 P42330 1/20 0.56
HPGD P15428 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
MAPT P10636 1/20 0.54
RAB9A P51151 1/20 0.54
FFAR1 O14842 1/20 0.52
TSPO P30536 1/20 0.52
PTGS1 P23219 1/20 0.52
EPHX1 P07099 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diphenylether SCHEMBL29175285 1.00 LTA4H (0.67) LTA4HTSHRPARP10NR1H2BAX
Diphenylether SCHEMBL8671677 0.97 LTA4H (0.63) LTA4HTSHRPARP10NR1H2BAX
Diphenylether SCHEMBL29116059 0.95 LTA4H (0.60) LTA4HTSHRPARP10NR1H2BAX
Diphenylether SCHEMBL28412058 0.94 LTA4H (0.67) LTA4HTSHRPARP10NR1H2BAX
Diphenylether SCHEMBL896890 0.91 LTA4H (0.55) LTA4HTSHRPARP10NR1H2BAX
Diphenylether SCHEMBL1965337 0.88 LTA4H (0.75) LTA4HTSHRPARP10NR1H2BAX
Diphenylether SCHEMBL360280 0.88 LTA4H (0.75) LTA4HTSHRPARP10NR1H2BAX
Diphenylether SCHEMBL5606885 0.88 LTA4H (0.75) LTA4HTSHRPARP10NR1H2BAX
Diphenylether SCHEMBL28186429 0.87 HPGD (0.60) LTA4HTSHRPARP10NR1H2BAX
Acetic Acid SCHEMBL9995157 0.87 PPARG (0.55) LTA4HTSHRPARP10NR1H2BAX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117466536-A Glass powder for slurry, preparation method of glass powder, conductive slurry, preparation method of conductive slurry and battery 常州聚和新材料股份有限公司 2024-01-30 CN claimed
CN-114392949-A High-efficiency complete splicing glue removing process for electroplating roller 扬州景如源电镀设备配件有限公司 2022-04-26 CN claimed
CN-109563363-A For producing the preparation and technique of high conductivity copper pattern 铜打印科技有限公司 2019-04-02 CN claimed
CN-106898270-A A kind of Ultrathin flexible LED display screen 深圳市美亚迪光电有限公司 2017-06-27 CN claimed
CN-103269727-B Water-based air freshener compositions, systems, and methods of use thereof 阿吉莱克斯香料和香水公司 2017-03-29 CN claimed
CN-104892904-A Interlayer insulation material for multilayer printed circuit board and preparation process thereof XINGNING JINGWEIJIN ELECTRONICS CO LTD 2015-09-09 CN claimed
WO-2024242121-A1 PATTERN FORMING METHOD AND PROCESSING LIQUID FOR METAL COMPOUND-CONTAINING FILM 東京応化工業株式会社 2024-11-28 WO disclosed
CN-117466536-A Glass powder for slurry, preparation method of glass powder, conductive slurry, preparation method of conductive slurry and battery 常州聚和新材料股份有限公司 2024-01-30 CN disclosed
US-20230399520-A1 A METHOD OF MAKING A THREE-DIMENSIONAL PRINTED CARBON-BONDED COMPOSITE ARTICLE ARKEMA FRANCE (FR) 2023-12-14 US disclosed
US-20230391936-A1 ACTINICALLY CURABLE COMPOSITIONS FOR ABLATIVE CARBON-BONDED COMPOSITES AND ADDITIVE MANUFACTURING METHOD USING SUCH COMPOSITIONS ARKEMA FRANCE (FR) 2023-12-07 US disclosed
US-20230285268-A1 AQUEOUS EMULSION BASED ANTIPERSPIRANT FORMULATION UNION CARBIDE CORPORATION 2023-09-14 US disclosed
EP-4232483-A1 ACTINICALLY CURABLE COMPOSITIONS FOR ABLATIVE CARBON-BONDED COMPOSITES AND ADDITIVE MANUFACTURING METHOD USING SUCH COMPOSITIONS ARKEMA FRANCE (FR) 2023-08-30 EP disclosed
EP-4232282-A1 A METHOD OF MAKING A THREE-DIMENSIONAL PRINTED CARBON-BONDED COMPOSITE ARTICLE ARKEMA FRANCE (FR) 2023-08-30 EP disclosed
EP-1595619-A1 METHOD FOR INTEGRALLY FORMING RESIN MODEL Shonan Design Co., Ltd. (JP) 2005-11-16 EP disclosed
CN-1603953-A Photoresist composite and image forming method using the same TOKYO APPLIED CHEMICAL INDUSTR (JP) 2005-04-06 CN disclosed
US-6630742-B2 Method for forming bumps, semiconductor device, and solder paste FUJITSU LIMITED (JP) 2003-10-07 US disclosed
CN-1408339-A Skin external preparation SHISEIDO CO LTD (JP) 2003-04-09 CN disclosed
EP-0277244-B1 SPHERICAL CLAY MINERAL POWDER, PROCESS FOR ITS PRODUCTION, AND COMPOSITION CONTAINING SAME SHISEIDO CO LTD (JP) 1994-09-21 EP disclosed
EP-0277244-A1 SPHERICAL CLAY MINERAL POWDER, PROCESS FOR ITS PRODUCTION, AND COMPOSITION CONTAINING SAME SHISEIDO COMPANY LIMITED (JP) 1988-08-10 EP disclosed
EP-0270316-A2 Topical compositions comprising 1-substituted imidazoles and NSAIDs for treatment of acne PFIZER INC. (US) 1988-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230285268-A1 AQUEOUS EMULSION BASED ANTIPERSPIRANT FORMULATION ADH1A, ALOX5, PON1 LTA4H 523/4885TSHR 1840/4885PARP10 3393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.